15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| 2025 | $9M | -$49M | 29.5% | -552.6% | -$37M | — | $9M |
| 2024 | $7M | -$32M | 21.5% | -478.0% | -$23M | — | $19M |
| 2023 | $6M | -$20M | 29.1% | -340.7% | -$17M | — | $10M |
| 2022 | $5M | -$18M | 21.6% | -361.9% | -$16M | — | $5M |
| 2021 | $4M | -$15M | 16.8% | -327.4% | -$14M | — | $12M |
| 2020 | $2M | -$11M | 3.3% | -417.7% | -$9M | — | $13M |
| 2019 | $4M | -$10M | 20.3% | -263.8% | -$10M | — | $6M |
| 2018 | $4M | -$7M | 27.6% | -211.4% | -$8M | — | $9M |
| 2017 | $3M | -$8M | 21.2% | -298.2% | -$8M | — | $4M |
| 2016 | — | -$8M | — | — | — | — | $8M |
| 2015 | — | -$16M | — | — | — | $5M | $3M |
| 2014 | — | -$25M | — | — | — | $9M | $6M |
| 2013 | — | -$29M | — | — | -$11M | — | $15M |
| 2012 | — | -$18M | — | — | -$9M | — | $10M |
| 2011 | — | -$15M | — | — | -$6M | — | $5M |
| Quarter | Revenue | Net income | Gross M | Op M | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|
| Mar '26 | $3M | -$14M | 20.2% | -411.4% | -$13M | — | $11M |
| Dec '25 | $3M | -$12M | 37.5% | -383.7% | -$10M | — | $9M |
| Sep '25 | $3M | -$13M | 34.2% | -517.3% | -$9M | — | $63M |
| Jun '25 | $2M | -$13M | 17.6% | -732.2% | -$9M | — | $12M |
| Mar '25 | $2M | -$11M | 19.1% | -749.5% | -$9M | — | $12M |
| Dec '24 | $2M | -$9M | 24.1% | -480.6% | -$7M | — | $19M |
| Sep '24 | $2M | -$8M | 22.9% | -467.5% | -$6M | — | $16M |
| Jun '24 | $2M | -$8M | 19.0% | -475.0% | -$5M | — | $28M |
| Mar '24 | $2M | -$7M | 19.3% | -490.7% | -$5M | — | $9M |
| Dec '23 | $2M | -$5M | 28.7% | -329.8% | -$4M | — | $10M |
| Sep '23 | $2M | -$5M | 28.1% | -362.4% | -$4M | — | $14M |
| Jun '23 | $2M | -$5M | 29.8% | -322.3% | -$3M | — | $12M |
| Mar '23 | $1M | -$4M | 30.1% | -353.6% | -$5M | — | $4M |
| Dec '22 | $1M | -$5M | 19.3% | -481.1% | -$3M | — | $5M |
| Sep '22 | $1M | -$5M | 25.6% | -322.2% | -$5M | — | $4M |
| Jun '22 | $2M | -$5M | 28.2% | -305.7% | -$3M | — | $6M |
| Mar '22 | $1M | -$4M | 10.3% | -379.2% | -$4M | — | $8M |
| Dec '21 | $1M | -$4M | 21.3% | -284.9% | -$3M | — | $12M |
| Sep '21 | $1M | -$4M | 8.6% | -376.4% | -$4M | — | $13M |
| Jun '21 | $1M | -$4M | 25.2% | -331.4% | -$3M | — | $41M |
How the market has priced NSPR against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
Over the past 5 years, InspireMD, Inc.'s revenue has grown 29.3% per year. These are computed facts, not advice.
As of FY2025, InspireMD, Inc. reported — of total debt against $9M of cash.
In FY2025, gross margin was 29.5%, operating margin -552.6%, and net margin -543.4%.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.